Editorial
doi: 10.1097/JTO.0b013e3181f41b1c.
Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: deal or no deal?
- PMID: 20871257
- DOI: 10.1097/JTO.0b013e3181f41b1c
Item in Clipboard
Editorial
Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: deal or no deal?
J Thorac Oncol.
2010 Oct.
Free article
No abstract available
Comment on
-
Efficacy and safety of erlotinib in 1242 East/South-East Asian patients with advanced non-small cell lung cancer.J Thorac Oncol. 2010 Oct;5(10):1609-15. doi: 10.1097/JTO.0b013e3181e15d55. J Thorac Oncol. 2010. PMID: 20808255 Clinical Trial.
Similar articles
-
[TRUST study: general practice relevant data on erlotinib in NSCLC].Wien Med Wochenschr. 2007;157(21-22):579-80. doi: 10.1007/s10354-007-0492-9. Wien Med Wochenschr. 2007. PMID: 18157598 German. No abstract available.
-
Management of non-small cell lung cancer: focus on erlotinib. Foreword.Drugs. 2012 Jun 19;72 Suppl 1:1-2. doi: 10.2165/1163029-S0-000000000-00000. Drugs. 2012. PMID: 22712791 No abstract available.
-
Wood-smoke exposure as a response and survival predictor in erlotinib-treated nonsmall cell lung cancer patients.J Thorac Oncol. 2009 Aug;4(8):1043. doi: 10.1097/JTO.0b013e3181ae2497. J Thorac Oncol. 2009. PMID: 19633484 No abstract available.
-
Targeting HER1/EGFR in cancer therapy: experience with erlotinib.Future Oncol. 2005 Aug;1(4):449-60. doi: 10.2217/14796694.1.4.449. Future Oncol. 2005. PMID: 16556021 Review.
-
Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer.Expert Rev Anticancer Ther. 2011 Jul;11(7):991-7. doi: 10.1586/era.11.74. Expert Rev Anticancer Ther. 2011. PMID: 21806322 Review.
Cited by
-
Equity and capacity to benefit from early access to medicines schemes.Int J Equity Health. 2025 Apr 10;24(1):100. doi: 10.1186/s12939-025-02416-3. Int J Equity Health. 2025. PMID: 40211343 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
